[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab
Romain‐David Seban, Emilie Arnaud, Delphine Loirat, Luc Cabel, Paul Cottu, Lounes Djerroudi, S. Hescot, Pierre Loap, Claire Bonneau, François‐Clément Bidard, Virginie Huchet, Nina Jehanno, Arnaud Berenbaum, Laurence Champion, Irène Buvat
Topics & Concepts
MedicinePembrolizumabBreast cancerChemotherapyOncologyInternal medicineStandardized uptake valueCancerPositron emission tomographyTriple-negative breast cancerRetrospective cohort studyNeoadjuvant therapyStage (stratigraphy)CohortImmunotherapyNuclear medicineBiologyPaleontologyMedical Imaging Techniques and ApplicationsBreast Cancer Treatment StudiesCancer Immunotherapy and Biomarkers